Abstract
A number of pathophysiological conditions are related to iron metabolism disturbances. Some of them are well known, others are newly discovered or special. Hepcidin is a newly identified iron metabolism regulating hormone, which could be a promising biomarker for many disorders. In this review, we provide background information about mammalian iron metabolism, cellular iron trafficking, and the regulation of expression of hepcidin. Beside these molecular biological processes, we summarize the methods that have been used to determine blood and urine hepcidin levels and present those pathological conditions (cancer, inflammation, neurological disorders) when hepcidin measurement may have clinical relevance.
Funding Information
  • Research Fund of the University of Pecs, Faculty of Medicine (ÁOK-KA 2013/19)
  • New Széchenyi Plan (SROP-4.2.2.A-11/1/KONV-2012-0017)

This publication has 101 references indexed in Scilit: